Welcome to our dedicated page for Tactile Systems news (Ticker: TCMD), a resource for investors and traders seeking the latest updates and insights on Tactile Systems stock.
Tactile Systems Technology Inc (NASDAQ: TCMD) delivers innovative medical solutions for chronic conditions through advanced home therapy devices. This news hub provides investors and healthcare professionals with essential updates on corporate developments, clinical advancements, and regulatory milestones.
Track key updates including quarterly earnings reports, new product clearances, partnership announcements, and clinical study results. Our curated collection ensures access to verified press releases and objective market analysis related to lymphedema management and venous insufficiency treatments.
Discover comprehensive coverage of TCMD's operational progress, including FDA submissions, insurance reimbursement developments, and technological innovations in pneumatic compression therapy. All content is maintained to meet strict journalistic standards for accuracy and relevance in the medical device sector.
Bookmark this page for streamlined access to Tactile Systems' latest announcements and historical performance data. Check regularly for updates that could impact understanding of the company's market position in home-based chronic care solutions.
Tactile Systems Technology, Inc. (TCMD) will release its financial results for the first quarter of fiscal year 2023 on May 8, 2023, before market open.
Management will host a conference call at 5:00 p.m. ET to discuss these results, available via phone and live webcast. Tactile Medical specializes in therapies for chronic disorders like lymphedema and chronic pulmonary disease, focusing on enhancing patient care and reducing healthcare costs. The company's commitment to improving quality of life continues as it collaborates with clinicians to expand clinical evidence and access to care.